DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
DOVA
Delisted
DOVA was delisted on the 11th of November, 2019.
60 hedge funds and large institutions have $309M invested in Dova Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+5
Holders Change %
+9.09%
% of All Funds
1.38%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
18
Increased
27
Reduced
10
Closed
13
Calls
$30K
Puts
–
Net Calls
+$30K
Net Calls Change
+$30K
Top Buyers
| 1 |
BlackRock
New York
|
+$14.8M |
| 2 |
PA
Perceptive Advisors
New York
|
+$10.3M |
| 3 |
NC
Nexthera Capital
New York
|
+$7.54M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.45M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.96M |
Top Sellers
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$12.6M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$11.7M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
-$5.91M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$4.99M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$3.39M |
